Page last updated: 2024-08-24

3-iodobenzylguanidine and Wolff-Parkinson-White Syndrome

3-iodobenzylguanidine has been researched along with Wolff-Parkinson-White Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akutsu, Y; Asano, T; Gokan, T; Kaneko, K; Kobayashi, Y; Kodama, Y; Li, HL; Namiki, A; Shinozuka, A; Suyama, J; Tanno, K	1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Wolff-Parkinson-White Syndrome

Article	Year
Usefulness of severe cardiac sympathetic dysfunction to predict the occurrence of rapid atrial fibrillation in patients with Wolff-Parkinson-White syndrome. The American journal of cardiology, 2013, Sep-01, Volume: 112, Issue:5 Topics: 3-Iodobenzylguanidine; Adult; Aged; Atrial Fibrillation; Case-Control Studies; Electrophysiologic Techniques, Cardiac; Female; Heart; Humans; Male; Mediastinum; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Severity of Illness Index; Sympathetic Nervous System; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome	2013

Article

Year

Usefulness of severe cardiac sympathetic dysfunction to predict the occurrence of rapid atrial fibrillation in patients with Wolff-Parkinson-White syndrome.

The American journal of cardiology, 2013, Sep-01, Volume: 112, Issue:5

Topics: 3-Iodobenzylguanidine; Adult; Aged; Atrial Fibrillation; Case-Control Studies; Electrophysiologic Techniques, Cardiac; Female; Heart; Humans; Male; Mediastinum; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Severity of Illness Index; Sympathetic Nervous System; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome

2013